» Articles » PMID: 28603694

Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk

Overview
Journal Front Oncol
Specialty Oncology
Date 2017 Jun 13
PMID 28603694
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

A woman has an increased risk of breast cancer if her lifelong estrogen exposure is increased due to an early menarche, a late menopause, and/or an absence of childbearing. For decades, it was presumed that the number of years of exposure drove the increased risk, however, recent epidemiological data have shown that early life exposure (young menarche) has a more significant effect on cancer risk than late menopause. Thus, rather than the overall exposure it seems that the timing of hormone exposure plays a major role in defining breast cancer risk. In support of this, it is also known that aberrant hormonal exposure prior to puberty can also increase breast cancer risk, yet the elevated estrogen levels during pregnancy decrease breast cancer risk. This suggests that the effects of estrogen on the mammary gland/breast are age-dependent. In this review article, we will discuss the existing epidemiological data linking hormone exposure and estrogen receptor-positive breast cancer risk including menarche, menopause, parity, and aberrant environmental hormone exposure. We will discuss the predominantly rodent generated experimental data that confirm the association with hormone exposure and breast cancer risk, confirming its use as a model system. We will review the work that has been done attempting to define the direct effects of estrogen on the breast, which are beginning to reveal the mechanism of increased cancer risk. We will then conclude with our views on the most pertinent questions to be addressed experimentally in order to explore the relationship between age, estrogen exposure, and breast cancer risk.

Citing Articles

A Global Regional Comparison of the Risk of Breast Cancer in Woman Using Oral Contraceptives-Systematic Review and Meta-Analysis.

Drab A, Wdowiak K, Kanadys W, Malm M, Dolar-Szczasny J, Zielinski G Cancers (Basel). 2024; 16(23).

PMID: 39682230 PMC: 11639980. DOI: 10.3390/cancers16234044.


Unveiling the Link Between Breast Cancer Treatment and Osteoporosis: Implications for Anticancer Therapy and Bone Health.

Goel B, Virmani T, Jain V, Kumar G, Sharma A, Al Noman A Biomed Res Int. 2024; 2024:5594542.

PMID: 39574432 PMC: 11581800. DOI: 10.1155/2024/5594542.


Worse Clinical and Survival Outcomes in Breast Cancer Patients Living in Puerto Rico Compared to Hispanics, Non-Hispanic Blacks, and Non-Hispanic Whites from Florida.

Lantz A, Gebert R, Li J, Oliveras J, Gordian E, Perez-Morales J J Racial Ethn Health Disparities. 2024; .

PMID: 39543072 DOI: 10.1007/s40615-024-02232-5.


Enhancing health and therapeutic potential: innovations in the medicinal and pharmaceutical properties of soy bioactive compounds.

Rahman U, Younas Z, Ahmad I, Yousaf T, Latif R, Rubab U Front Pharmacol. 2024; 15:1397872.

PMID: 39421675 PMC: 11483366. DOI: 10.3389/fphar.2024.1397872.


Theranostics: aptamer-assisted carbon nanotubes as MRI contrast and photothermal agent for breast cancer therapy.

Khajuria A, Alajangi H, Sharma A, Kaur H, Sharma P, Negi S Discov Nano. 2024; 19(1):145.

PMID: 39256285 PMC: 11387581. DOI: 10.1186/s11671-024-04095-5.


References
1.
Kato I, Miura S, Kasumi F, Iwase T, Tashiro H, Fujita Y . A case-control study of breast cancer among Japanese women: with special reference to family history and reproductive and dietary factors. Breast Cancer Res Treat. 1992; 24(1):51-9. DOI: 10.1007/BF01832358. View

2.
He L, Xiong D, Liu Y, Zhang F, Recker R, Deng H . Association study of the oestrogen signalling pathway genes in relation to age at natural menopause. J Genet. 2008; 86(3):269-76. DOI: 10.1007/s12041-007-0034-7. View

3.
Cardiff R . The biology of mammary transgenes: five rules. J Mammary Gland Biol Neoplasia. 1996; 1(1):61-73. DOI: 10.1007/BF02096303. View

4.
Glass A, Hoover R . Rising incidence of breast cancer: relationship to stage and receptor status. J Natl Cancer Inst. 1990; 82(8):693-6. DOI: 10.1093/jnci/82.8.693. View

5.
Anderson S, Must A . Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr. 2005; 147(6):753-60. DOI: 10.1016/j.jpeds.2005.07.016. View